ID	4V01A	STANDARD;	PRT;	309	AA.
DT	CONVERTED FROM PDB (SEQRES) 4V01
DE	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFE
DE	R SYNDROME), ISOFORM CRA_B
OS	HOMO SAPIENS
CC	EXPDTA	X-RAY DIFFRACTION
CC	RESOLU	2.330
CC	R-Factor	0.191
FT	#SUB	246	 702 	PRO	A	248	 704 	VAL	B	Protein	B	1
FT	#SUB	246	 702 	PRO	A	261	 717 	HIS	B	Protein	S	3
FT	#SUB	247	 703 	GLY	A	248	 704 	VAL	B	Protein	B	4
FT	#SUB	247	 703 	GLY	A	249	 705 	PRO	B	Protein	B	1
FT	#SUB	247	 703 	GLY	A	252	 708 	GLU	B	Protein	B	2
FT	#SUB	248	 704 	VAL	A	246	 702 	PRO	B	Protein	S	1
FT	#SUB	248	 704 	VAL	A	247	 703 	GLY	B	Protein	A	5
FT	#SUB	248	 704 	VAL	A	248	 704 	VAL	B	Protein	S	1
FT	#SUB	249	 705 	PRO	A	247	 703 	GLY	B	Protein	S	1
FT	#SUB	249	 705 	PRO	A	249	 705 	PRO	B	Protein	S	4
FT	#SUB	249	 705 	PRO	A	252	 708 	GLU	B	Protein	S	1
FT	#SUB	252	 708 	GLU	A	247	 703 	GLY	B	Protein	S	2
FT	#SUB	252	 708 	GLU	A	249	 705 	PRO	B	Protein	S	1
FT	#SUB	256	 712 	LEU	A	246	 702 	PRO	B	Protein	S	1
FT	#SUB	261	 717 	HIS	A	246	 702 	PRO	B	Protein	S	2
FT	#SUB	265	 721 	LYS	A	267	 723 	SER	B	Protein	S	1
FT	#SUB	267	 723 	SER	A	265	 721 	LYS	B	Protein	A	4
FT	#HET	14	 470 	ARG	A	1	1766 	SO4	A	B	1
FT	#HET	14	 470 	ARG	A	4	1769 	SO4	A	S	8
FT	#HET	14	 470 	ARG	A	9	1774 	EDO	A	A	5
FT	#HET	15	 471 	TRP	A	1	1766 	SO4	A	B	7
FT	#HET	15	 471 	TRP	A	9	1774 	EDO	A	S	3
FT	#HET	16	 472 	GLU	A	1	1766 	SO4	A	B	4
FT	#HET	17	 473 	LEU	A	1	1766 	SO4	A	S	1
FT	#HET	28	 484 	LEU	A	11	1776 	0LI	A	S	2
FT	#HET	36	 492 	VAL	A	11	1776 	0LI	A	S	2
FT	#HET	44	 500 	LEU	A	1	1766 	SO4	A	B	3
FT	#HET	56	 512 	ALA	A	11	1776 	0LI	A	S	3
FT	#HET	57	 513 	VAL	A	11	1776 	0LI	A	B	1
FT	#HET	58	 514 	LYS	A	11	1776 	0LI	A	A	4
FT	#HET	75	 531 	GLU	A	11	1776 	0LI	A	S	9
FT	#HET	78	 534 	MET	A	5	1770 	EDO	A	S	1
FT	#HET	78	 534 	MET	A	11	1776 	0LI	A	S	4
FT	#HET	79	 535 	MET	A	11	1776 	0LI	A	S	7
FT	#HET	82	 538 	ILE	A	11	1776 	0LI	A	S	1
FT	#HET	83	 539 	GLY	A	3	1768 	SO4	A	B	2
FT	#HET	84	 540 	LYS	A	3	1768 	SO4	A	A	7
FT	#HET	89	 545 	ILE	A	11	1776 	0LI	A	S	3
FT	#HET	92	 548 	LEU	A	1	1766 	SO4	A	B	3
FT	#HET	93	 549 	GLY	A	1	1766 	SO4	A	B	1
FT	#HET	105	 561 	VAL	A	11	1776 	0LI	A	S	7
FT	#HET	106	 562 	GLU	A	11	1776 	0LI	A	B	2
FT	#HET	107	 563 	TYR	A	11	1776 	0LI	A	A	4
FT	#HET	108	 564 	ALA	A	11	1776 	0LI	A	A	8
FT	#HET	116	 572 	TYR	A	10	1775 	EDO	A	S	4
FT	#HET	139	 595 	LEU	A	10	1775 	EDO	A	S	1
FT	#HET	141	 597 	SER	A	2	1767 	SO4	A	S	6
FT	#HET	143	 599 	ASP	A	10	1775 	EDO	A	A	2
FT	#HET	145	 601 	VAL	A	2	1767 	SO4	A	S	1
FT	#HET	146	 602 	SER	A	10	1775 	EDO	A	S	1
FT	#HET	147	 603 	CYS	A	10	1775 	EDO	A	S	3
FT	#HET	150	 606 	GLN	A	10	1775 	EDO	A	S	2
FT	#HET	158	 614 	LEU	A	11	1776 	0LI	A	S	3
FT	#HET	159	 615 	ALA	A	7	1772 	EDO	A	S	1
FT	#HET	162	 618 	LYS	A	5	1770 	EDO	A	B	2
FT	#HET	163	 619 	CYS	A	5	1770 	EDO	A	B	2
FT	#HET	164	 620 	ILE	A	5	1770 	EDO	A	A	4
FT	#HET	164	 620 	ILE	A	11	1776 	0LI	A	B	4
FT	#HET	165	 621 	HIS	A	11	1776 	0LI	A	A	7
FT	#HET	166	 622 	ARG	A	11	1776 	0LI	A	S	2
FT	#HET	174	 630 	LEU	A	11	1776 	0LI	A	S	5
FT	#HET	179	 635 	ASN	A	10	1775 	EDO	A	B	2
FT	#HET	181	 637 	MET	A	10	1775 	EDO	A	S	1
FT	#HET	183	 639 	ILE	A	11	1776 	0LI	A	A	3
FT	#HET	184	 640 	ALA	A	11	1776 	0LI	A	A	7
FT	#HET	185	 641 	ASP	A	11	1776 	0LI	A	A	11
FT	#HET	186	 642 	PHE	A	11	1776 	0LI	A	S	3
FT	#HET	200	 656 	LYS	A	8	1773 	EDO	A	S	3
FT	#HET	206	 662 	LEU	A	8	1773 	EDO	A	S	2
FT	#HET	223	 679 	HIS	A	7	1772 	EDO	A	S	2
FT	#HET	228	 684 	TRP	A	6	1771 	EDO	A	S	3
FT	#HET	232	 688 	VAL	A	6	1771 	EDO	A	S	1
FT	#HET	238	 694 	PHE	A	2	1767 	SO4	A	S	2
FT	#HET	245	 701 	TYR	A	6	1771 	EDO	A	S	2
FT	#HET	247	 703 	GLY	A	8	1773 	EDO	A	B	3
FT	#HET	248	 704 	VAL	A	8	1773 	EDO	A	B	2
FT	#HET	249	 705 	PRO	A	8	1773 	EDO	A	A	4
FT	#HET	262	 718 	ARG	A	6	1771 	EDO	A	A	4
FT	#HET	263	 719 	MET	A	6	1771 	EDO	A	A	6
FT	#HET	268	 724 	ASN	A	2	1767 	SO4	A	B	5
FT	#HET	269	 725 	CYS	A	2	1767 	SO4	A	B	2
FT	#HET	270	 726 	THR	A	2	1767 	SO4	A	A	8
FT	#HET	273	 729 	LEU	A	2	1767 	SO4	A	S	3
FT	#HET	281	 737 	TRP	A	6	1771 	EDO	A	S	11
FT	#HET	290	 746 	THR	A	7	1772 	EDO	A	A	6
FT	#HET	291	 747 	PHE	A	7	1772 	EDO	A	A	9
FT	#HET	292	 748 	LYS	A	7	1772 	EDO	A	A	3
FT	#HET	305	 761 	THR	A	2	1767 	SO4	A	S	1
FT	DISORDER	1	8
FT	DISORDER	30	33
FT	DISORDER	46	47
FT	DISORDER	124	137
FT	DISORDER	187	194
CC	SEQUENCE	273 AA (ATOM);
CC	LPEDPRWELP RDRLVLGKPL GGQVVLAEAI GLDKPNRVTK VAVKMLKSDA TEKDLSDLIS
CC	EMEMMKMIGK HKNIINLLGA CTQDGPLYVI VEYASKGNLR EYLQARRPPQ LSSKDLVSCA
CC	YQVARGMEYL ASKKCIHRDL AARNVLVTED NVMKIADFID YYKKTTNGRL PVKWMAPEAL
CC	FDRIYTHQSD VWSFGVLLWE IFTLGGSPYP GVPVEELFKL LKEGHRMDKP SNCTNELYMM
CC	MRDCWHAVPS QRPTFKQLVE DLDRIVALTS NQE
CC	!----
CC	ALIGNMENT OF SEQRES AND ATOMRES
CC	SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN
CC	ATOM   --------LPEDPRWELPRDRLVLGKPLG----GQVVLAEAIGLD--KPN
CC	               *********************    ************  ***
CC	SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	ATOM   RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	       **************************************************
CC	SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ
CC	ATOM   LYVIVEYASKGNLREYLQARRPP--------------QLSSKDLVSCAYQ
CC	       ***********************              *************
CC	SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK
CC	ATOM   VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF--------IDYYKK
CC	       ************************************        ******
CC	SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	ATOM   TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	       **************************************************
CC	SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	ATOM   EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	       **************************************************
CC	SEQRES IVALTSNQE
CC	ATOM   IVALTSNQE
CC	       *********
SQ	SEQUENCE	309 AA;      MW;         CN;
	GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML
	KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR
	RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV
	MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL
	GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR
	IVALTSNQE
//
ID	4V01B	STANDARD;	PRT;	309	AA.
DT	CONVERTED FROM PDB (SEQRES) 4V01
DE	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFE
DE	R SYNDROME), ISOFORM CRA_B
OS	HOMO SAPIENS
CC	EXPDTA	X-RAY DIFFRACTION
CC	RESOLU	2.330
CC	R-Factor	0.191
FT	#SUB	246	 702 	PRO	B	248	 704 	VAL	A	Protein	B	1
FT	#SUB	246	 702 	PRO	B	256	 712 	LEU	A	Protein	B	1
FT	#SUB	246	 702 	PRO	B	261	 717 	HIS	A	Protein	S	2
FT	#SUB	247	 703 	GLY	B	248	 704 	VAL	A	Protein	B	5
FT	#SUB	247	 703 	GLY	B	249	 705 	PRO	A	Protein	B	1
FT	#SUB	247	 703 	GLY	B	252	 708 	GLU	A	Protein	B	2
FT	#SUB	248	 704 	VAL	B	246	 702 	PRO	A	Protein	S	1
FT	#SUB	248	 704 	VAL	B	247	 703 	GLY	A	Protein	A	4
FT	#SUB	248	 704 	VAL	B	248	 704 	VAL	A	Protein	S	1
FT	#SUB	249	 705 	PRO	B	247	 703 	GLY	A	Protein	S	1
FT	#SUB	249	 705 	PRO	B	249	 705 	PRO	A	Protein	S	4
FT	#SUB	249	 705 	PRO	B	252	 708 	GLU	A	Protein	S	1
FT	#SUB	252	 708 	GLU	B	247	 703 	GLY	A	Protein	S	2
FT	#SUB	252	 708 	GLU	B	249	 705 	PRO	A	Protein	S	1
FT	#SUB	261	 717 	HIS	B	246	 702 	PRO	A	Protein	S	3
FT	#SUB	265	 721 	LYS	B	267	 723 	SER	A	Protein	A	4
FT	#SUB	267	 723 	SER	B	265	 721 	LYS	A	Protein	S	1
FT	#HET	10	 466 	PRO	B	16	1768 	EDO	B	A	6
FT	#HET	28	 484 	LEU	B	18	1770 	0LI	B	S	1
FT	#HET	36	 492 	VAL	B	18	1770 	0LI	B	S	1
FT	#HET	56	 512 	ALA	B	18	1770 	0LI	B	A	5
FT	#HET	57	 513 	VAL	B	18	1770 	0LI	B	B	2
FT	#HET	58	 514 	LYS	B	18	1770 	0LI	B	A	7
FT	#HET	73	 529 	ILE	B	16	1768 	EDO	B	S	1
FT	#HET	75	 531 	GLU	B	18	1770 	0LI	B	S	9
FT	#HET	76	 532 	MET	B	16	1768 	EDO	B	S	3
FT	#HET	77	 533 	GLU	B	16	1768 	EDO	B	S	5
FT	#HET	78	 534 	MET	B	18	1770 	0LI	B	S	4
FT	#HET	79	 535 	MET	B	17	1769 	EDO	B	A	8
FT	#HET	79	 535 	MET	B	18	1770 	0LI	B	S	2
FT	#HET	80	 536 	LYS	B	16	1768 	EDO	B	S	1
FT	#HET	82	 538 	ILE	B	18	1770 	0LI	B	S	1
FT	#HET	83	 539 	GLY	B	17	1769 	EDO	B	B	4
FT	#HET	84	 540 	LYS	B	17	1769 	EDO	B	B	2
FT	#HET	88	 544 	ILE	B	17	1769 	EDO	B	S	2
FT	#HET	89	 545 	ILE	B	17	1769 	EDO	B	B	4
FT	#HET	89	 545 	ILE	B	18	1770 	0LI	B	S	2
FT	#HET	90	 546 	ASN	B	17	1769 	EDO	B	A	5
FT	#HET	91	 547 	LEU	B	17	1769 	EDO	B	A	5
FT	#HET	96	 552 	THR	B	16	1768 	EDO	B	S	3
FT	#HET	103	 559 	VAL	B	18	1770 	0LI	B	B	1
FT	#HET	105	 561 	VAL	B	18	1770 	0LI	B	S	7
FT	#HET	106	 562 	GLU	B	18	1770 	0LI	B	B	2
FT	#HET	107	 563 	TYR	B	18	1770 	0LI	B	A	4
FT	#HET	108	 564 	ALA	B	18	1770 	0LI	B	A	7
FT	#HET	114	 570 	ARG	B	12	1764 	SO4	B	S	9
FT	#HET	119	 575 	ALA	B	14	1766 	EDO	B	B	2
FT	#HET	141	 597 	SER	B	13	1765 	SO4	B	S	3
FT	#HET	145	 601 	VAL	B	13	1765 	SO4	B	S	1
FT	#HET	158	 614 	LEU	B	18	1770 	0LI	B	S	2
FT	#HET	163	 619 	CYS	B	18	1770 	0LI	B	S	1
FT	#HET	164	 620 	ILE	B	18	1770 	0LI	B	B	4
FT	#HET	165	 621 	HIS	B	18	1770 	0LI	B	A	7
FT	#HET	166	 622 	ARG	B	18	1770 	0LI	B	S	1
FT	#HET	171	 627 	ARG	B	12	1764 	SO4	B	S	5
FT	#HET	174	 630 	LEU	B	18	1770 	0LI	B	S	5
FT	#HET	183	 639 	ILE	B	18	1770 	0LI	B	A	3
FT	#HET	184	 640 	ALA	B	18	1770 	0LI	B	A	7
FT	#HET	185	 641 	ASP	B	18	1770 	0LI	B	A	15
FT	#HET	186	 642 	PHE	B	18	1770 	0LI	B	S	6
FT	#HET	201	 657 	THR	B	12	1764 	SO4	B	S	4
FT	#HET	203	 659 	ASN	B	12	1764 	SO4	B	S	3
FT	#HET	205	 661 	ARG	B	12	1764 	SO4	B	S	13
FT	#HET	228	 684 	TRP	B	15	1767 	EDO	B	S	2
FT	#HET	238	 694 	PHE	B	13	1765 	SO4	B	S	5
FT	#HET	245	 701 	TYR	B	15	1767 	EDO	B	S	3
FT	#HET	252	 708 	GLU	B	8	1773 	EDO	A	S	6
FT	#HET	257	 713 	LEU	B	15	1767 	EDO	B	S	1
FT	#HET	262	 718 	ARG	B	15	1767 	EDO	B	A	3
FT	#HET	263	 719 	MET	B	15	1767 	EDO	B	A	5
FT	#HET	268	 724 	ASN	B	13	1765 	SO4	B	B	5
FT	#HET	269	 725 	CYS	B	13	1765 	SO4	B	B	3
FT	#HET	270	 726 	THR	B	13	1765 	SO4	B	A	3
FT	#HET	273	 729 	LEU	B	13	1765 	SO4	B	S	3
FT	#HET	281	 737 	TRP	B	15	1767 	EDO	B	S	6
FT	DISORDER	1	4
FT	DISORDER	32	33
FT	DISORDER	46	48
FT	DISORDER	123	137
FT	DISORDER	187	194
FT	DISORDER	308	309
CC	SEQUENCE	275 AA (ATOM);
CC	SEYELPEDPR WELPRDRLVL GKPLGEGGQV VLAEAIGLDP NRVTKVAVKM LKSDATEKDL
CC	SDLISEMEMM KMIGKHKNII NLLGACTQDG PLYVIVEYAS KGNLREYLQA RRPQLSSKDL
CC	VSCAYQVARG MEYLASKKCI HRDLAARNVL VTEDNVMKIA DFIDYYKKTT NGRLPVKWMA
CC	PEALFDRIYT HQSDVWSFGV LLWEIFTLGG SPYPGVPVEE LFKLLKEGHR MDKPSNCTNE
CC	LYMMMRDCWH AVPSQRPTFK QLVEDLDRIV ALTSN
CC	!----
CC	ALIGNMENT OF SEQRES AND ATOMRES
CC	SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN
CC	ATOM   ----SEYELPEDPRWELPRDRLVLGKPLGEG--GQVVLAEAIGLD---PN
CC	           ***************************  ************   **
CC	SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	ATOM   RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP
CC	       **************************************************
CC	SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ
CC	ATOM   LYVIVEYASKGNLREYLQARRP---------------QLSSKDLVSCAYQ
CC	       **********************               *************
CC	SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK
CC	ATOM   VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF--------IDYYKK
CC	       ************************************        ******
CC	SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	ATOM   TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV
CC	       **************************************************
CC	SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	ATOM   EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR
CC	       **************************************************
CC	SEQRES IVALTSNQE
CC	ATOM   IVALTSN--
CC	       *******  
SQ	SEQUENCE	309 AA;      MW;         CN;
	GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML
	KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR
	RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV
	MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL
	GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR
	IVALTSNQE
//